title: [The comparative effectiveness of framycetin included in combined therapy of adenoiditis in the children].
abstract: The objective of the present study was to evaluate the effectiveness of framycetin included in combined therapy of adenoiditis in the children. The study involved 67 children at the mean age of 6.9±2.7 years. Group 1 was comprised of 35 children given framycetin as topical therapy, the patients of group 2 were treated by the endonasal administration of a 2% silver proteinate solution. It was shown that the use of framycetin as a component of combined therapy of adenoiditis enhances the effectiveness of the treatment and compliance to therapy in comparison with the same parameters in the case of the application of traditional topical antibacterial preparations.
authors.affiliation: Kafedra otorinolaringologii pediatricheskogo fakul'teta RNIMU im. N.I. Pirogova, Moskva, Rossiia, 117997; Morozovskaia DGKB Depertamenta zdravookhraneniia Moskvy, Moskva, Rossiia, 119049.
authors.forename: Iu L
authors.initials: IuL
authors.lastname: Soldatskiĭ
authors.affiliation: Morozovskaia DGKB Depertamenta zdravookhraneniia Moskvy, Moskva, Rossiia, 119049.
authors.forename: O A
authors.initials: OA
authors.lastname: Denisova
authors.affiliation: Morozovskaia DGKB Depertamenta zdravookhraneniia Moskvy, Moskva, Rossiia, 119049.
authors.forename: A M
authors.initials: AM
authors.lastname: Ivanenko
mesh_terms: D000293:Adolescent; D000891:Anti-Infective Agents, Local / Q000008:administration & dosage / Q000494:pharmacology*; D002648:Child; D002675:Child, Preschool; D003131:Combined Modality Therapy; D005260:Female; D005601:Framycetin / Q000008:administration & dosage / Q000494:pharmacology*; D006801:Humans; D008297:Male; D055556:Nasal Lavage; D012836:Silver Proteins / Q000008:administration & dosage / Q000494:pharmacology*; D014069:Tonsillitis / Q000188:drug therapy*; D016896:Treatment Outcome
chemical_list: D000891:Anti-Infective Agents, Local; D012836:Silver Proteins; D005601:Framycetin